Xu C - Search Results

1

N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.

Sun LQ, Takaki K, Chen J, Iben L, Knipe JO, Pajor L, Mahle CD, Ryan E, Xu C. Sun LQ, et al. Among authors: xu c. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5157-60. doi: 10.1016/j.bmcl.2004.07.055. Bioorg Med Chem Lett. 2004. PMID: 15380218

2

Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.

Sun LQ, Chen J, Mattson RJ, Epperson JR, Deskus JA, Li WS, Takaki K, Hodges DB, Iben L, Mahle CD, Ortiz A, Molstad D, Ryan E, Yeleswaram K, Xu C, Luo G. Sun LQ, et al. Among authors: xu c. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4381-4. doi: 10.1016/j.bmcl.2003.09.030. Bioorg Med Chem Lett. 2003. PMID: 14643330

3

Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.

Sun LQ, Chen J, Takaki K, Johnson G, Iben L, Mahle CD, Ryan E, Xu C. Sun LQ, et al. Among authors: xu c. Bioorg Med Chem Lett. 2004 Mar 8;14(5):1197-200. doi: 10.1016/j.bmcl.2003.12.052. Bioorg Med Chem Lett. 2004. PMID: 14980664

4

Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.

Sun LQ, Chen J, Bruce M, Deskus JA, Epperson JR, Takaki K, Johnson G, Iben L, Mahle CD, Ryan E, Xu C. Sun LQ, et al. Among authors: xu c. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3799-802. doi: 10.1016/j.bmcl.2004.04.082. Bioorg Med Chem Lett. 2004. PMID: 15203165

5

Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists.

Karageorge GN, Bertenshaw S, Iben L, Xu C, Sarbin N, Gentile A, Dubowchik GM. Karageorge GN, et al. Among authors: xu c. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5881-4. doi: 10.1016/j.bmcl.2004.09.024. Bioorg Med Chem Lett. 2004. PMID: 15501061

6

(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents.

Sun LQ, Takaki K, Chen J, Bertenshaw S, Iben L, Mahle CD, Ryan E, Wu D, Gao Q, Xu C. Sun LQ, et al. Among authors: xu c. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1345-9. doi: 10.1016/j.bmcl.2005.01.015. Bioorg Med Chem Lett. 2005. PMID: 15713384

7

(+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist.

Sit SY, Xie K, Jacutin-Porte S, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Wong H, Zhu J, Krishnananthan S, Gao Q, Verdoorn T, Johnson G. Sit SY, et al. Among authors: xu c. J Med Chem. 2002 Aug 15;45(17):3660-8. doi: 10.1021/jm0101545. J Med Chem. 2002. PMID: 12166939

8

Synthesis and SAR exploration of dinapsoline analogues.

Sit SY, Xie K, Jacutin-Porte S, Boy KM, Seanz J, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Verdoorn T, Johnson G, Nichols DE, Mailman RB. Sit SY, et al. Among authors: xu c. Bioorg Med Chem. 2004 Feb 15;12(4):715-34. doi: 10.1016/j.bmc.2003.11.015. Bioorg Med Chem. 2004. PMID: 14759732

9

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Burris KD, et al. Among authors: xu c. J Pharmacol Exp Ther. 2002 Jul;302(1):381-9. doi: 10.1124/jpet.102.033175. J Pharmacol Exp Ther. 2002. PMID: 12065741

10

The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1.

Han X, Civiello RL, Conway CM, Cook DA, Davis CD, Macci R, Pin SS, Ren SX, Schartman R, Signor LJ, Thalody G, Widmann KA, Xu C, Chaturvedula PV, Macor JE, Dubowchik GM. Han X, et al. Among authors: xu c. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4723-7. doi: 10.1016/j.bmcl.2012.05.074. Epub 2012 Jun 1. Bioorg Med Chem Lett. 2012. PMID: 22727645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,659 results

Search Page